Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Adenomatous Polyposis Coli
|
237 | 0.641 | 0.520 | 7 | 140753334 | missense variant | T/C;G | snv | 4.0E-06 | 0.010 | 1.000 | 1 | 2007 | 2007 | |||||
Carcinoma, Papillary
|
9 | 0.641 | 0.520 | 7 | 140753334 | missense variant | T/C;G | snv | 4.0E-06 | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||
Follicular neoplasm
|
5 | 0.641 | 0.520 | 7 | 140753334 | missense variant | T/C;G | snv | 4.0E-06 | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||
Malignant Neoplasms
|
1641 | 0.641 | 0.520 | 7 | 140753334 | missense variant | T/C;G | snv | 4.0E-06 | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||
Metastatic melanoma
|
42 | 0.641 | 0.520 | 7 | 140753334 | missense variant | T/C;G | snv | 4.0E-06 | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||
Papillary and follicular adenocarcinoma
|
2 | 0.641 | 0.520 | 7 | 140753334 | missense variant | T/C;G | snv | 4.0E-06 | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||
Papillary carcinoma, clear cell
|
2 | 0.641 | 0.520 | 7 | 140753334 | missense variant | T/C;G | snv | 4.0E-06 | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||
Poorly differentiated carcinoma
|
2 | 0.641 | 0.520 | 7 | 140753334 | missense variant | T/C;G | snv | 4.0E-06 | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||
Primary malignant neoplasm
|
1374 | 0.641 | 0.520 | 7 | 140753334 | missense variant | T/C;G | snv | 4.0E-06 | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||
Secondary malignant neoplasm of lymph node
|
188 | 0.641 | 0.520 | 7 | 140753334 | missense variant | T/C;G | snv | 4.0E-06 | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||
Splenic Marginal Zone B-Cell Lymphoma
|
4 | 0.641 | 0.520 | 7 | 140753334 | missense variant | T/C;G | snv | 4.0E-06 | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||
Thyroid Gland Noninvasive Follicular Neoplasm with Papillary-Like Nuclear Features
|
5 | 0.641 | 0.520 | 7 | 140753334 | missense variant | T/C;G | snv | 4.0E-06 | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||
Thyroid Nodule
|
17 | 0.641 | 0.520 | 7 | 140753334 | missense variant | T/C;G | snv | 4.0E-06 | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||
Follicular Variant Thyroid Gland Papillary Carcinoma
|
13 | 0.641 | 0.520 | 7 | 140753334 | missense variant | T/C;G | snv | 4.0E-06 | 0.020 | 1.000 | 2 | 2006 | 2015 | |||||
Neoplasm Metastasis
|
327 | 0.641 | 0.520 | 7 | 140753334 | missense variant | T/C;G | snv | 4.0E-06 | 0.020 | 1.000 | 2 | 2006 | 2016 | |||||
Secondary Neoplasm
|
85 | 0.641 | 0.520 | 7 | 140753334 | missense variant | T/C;G | snv | 4.0E-06 | 0.020 | 1.000 | 2 | 2006 | 2016 | |||||
Thyroid Gland Follicular Adenoma
|
14 | 0.641 | 0.520 | 7 | 140753334 | missense variant | T/C;G | snv | 4.0E-06 | 0.020 | 1.000 | 2 | 2003 | 2016 | |||||
Follicular adenoma
|
5 | 0.641 | 0.520 | 7 | 140753334 | missense variant | T/C;G | snv | 4.0E-06 | 0.030 | 1.000 | 3 | 2003 | 2018 | |||||
Follicular thyroid carcinoma
|
28 | 0.641 | 0.520 | 7 | 140753334 | missense variant | T/C;G | snv | 4.0E-06 | 0.030 | 1.000 | 3 | 2011 | 2016 | |||||
Papillary thyroid carcinoma
|
204 | 0.641 | 0.520 | 7 | 140753334 | missense variant | T/C;G | snv | 4.0E-06 | 0.070 | 0.857 | 7 | 2004 | 2019 | |||||
Noonan Syndrome
|
187 | 0.641 | 0.520 | 7 | 140753334 | missense variant | T/C;G | snv | 4.0E-06 | 0.700 | 1.000 | 4 | 2007 | 2016 | |||||
Adenocarcinoma of lung (disorder)
|
563 | 0.641 | 0.520 | 7 | 140753334 | missense variant | T/C;G | snv | 4.0E-06 | 0.700 | 1.000 | 1 | 2016 | 2016 | |||||
Adenocarcinoma of prostate
|
108 | 0.641 | 0.520 | 7 | 140753334 | missense variant | T/C;G | snv | 4.0E-06 | 0.700 | 1.000 | 1 | 2016 | 2016 | |||||
Chronic Lymphocytic Leukemia
|
291 | 0.641 | 0.520 | 7 | 140753334 | missense variant | T/C;G | snv | 4.0E-06 | 0.700 | 1.000 | 1 | 2016 | 2016 | |||||
Cutaneous Melanoma
|
248 | 0.641 | 0.520 | 7 | 140753334 | missense variant | T/C;G | snv | 4.0E-06 | 0.700 | 1.000 | 1 | 2016 | 2016 |